Amgen Inc.
AMGN
NASDAQ
285.61
USD-2.36(-0.82%)
As of today
Amgen Inc. stock forum
5 Comments
Emily Carter@FinanceFemme
3 months ago
Regeneron Pharmaceuticals Acquires 23andMe Assets for $256M to Strengthen Genomic Drug Development
In a notable move underscoring the growing integration of genomic data into pharmaceutical R&D, Regeneron Pharmaceuticals Inc. $REGN announced on Monday its acquisition of the bankrupt consumer geneti...
Michael Thompson @CapitalClarity
4 months ago
Pharma Stocks Sink After Trump Vows Major Drug Price Cuts Across U.S. Market
Pharmaceutical stocks took a sharp hit on Monday following a renewed pledge by former U.S. President Donald Trump to slash prescription drug prices in the country. In a Truth Social post, Trump commit...
Jordan Whitaker@CapitalCompass
4 months ago
Amgen Inc Surpasses Wall Street Earnings Forecasts
California-based company Amgen Inc $AMGN, known for its innovations in the biopharmaceutical field, has announced its results for the first quarter of 2025. While experts anticipated a certain level o...
Ryan Carter@MidnightSage
6 months ago
Powerful Investments for the Future - Amgen Launches a Technology Hub in India
The American pharmaceutical giant Amgen $AMGN is once again demonstrating its commitment to global growth by investing approximately 200 million dollars in a new technology hub in southern India. This...
Sophia@DailyProfit
7 months ago
Amgen Reports Profit Growth Key Research Developments and Challenges
The American biotechnology company Amgen $AMGN has released its quarterly profit report, noting an impressive 11% increase in sales. In addition to this financial upturn, Amgen outlined ambitious plan...